Immunoglobulin G antibodies to pneumococcal surface protein A (PspA) families in serum of adults with pneumococcal community-acquired pneumonia in China

Q. Ma, Q. Zhang, X. Zeng, C. Wang (Chongqing, China)

Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Session: Lower respiratory tract infection: from outbreak to prognostic tests
Session type: Thematic Poster Session
Number: 2239
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Q. Ma, Q. Zhang, X. Zeng, C. Wang (Chongqing, China). Immunoglobulin G antibodies to pneumococcal surface protein A (PspA) families in serum of adults with pneumococcal community-acquired pneumonia in China. Eur Respir J 2008; 32: Suppl. 52, 2239

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Genetic diversity of pneumococcal surface protein A (PspA) in Streptococcus pneumoniae isolates from community acquired pneumonia (CAP) in china
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008

Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia
Source: Eur Respir J 2010; 36: 1073-1079
Year: 2010



Use of serotype specific serology (IgA & IgG) in the etiologic diagnosis of childhood pneumococcal pneumonia: First results from the pediatric pneumococcal pneumonia (3P) trial
Source: Annual Congress 2010 - Childhood pneumonia: from prevention to complications
Year: 2010


Lower concentration of anti-capsular polysaccharide IgG antibodies (AB) in patients with pneumococcal respiratory tract infections (RTI)
Source: Eur Respir J 2003; 22: Suppl. 45, 546s
Year: 2003

The remaining challenges of pneumococcal disease in adults
Source: Eur Respir Rev 2012; 21: 57-65
Year: 2012



Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017


Characteristics of patients with serotype 5 pneumococcal pneumonia
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020


Downregulation of RTI40 /T1α protein in pneumococcal pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 719s
Year: 2004

Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017

A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany
Source: Eur Respir J, 59 (2) 2102432; 10.1183/13993003.02432-2021
Year: 2022



Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia
Source: Eur Respir J 2015; 45: 1632-1641
Year: 2015



Clinical presentations and serotypes causing invasive pneumococcal disease in adults vaccinated with the 23-valent polysaccharide pneumococcal vaccine (PPV23) in Spain. The ODIN study (2010-2013)
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014


Serum procalcitonin in pneumococcal pneumonia in children
Source: Eur Respir J 2001; 17: 623-627
Year: 2001



Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults
Source: Eur Respir J 2003; 21: 209-214
Year: 2003



Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine
Source: Eur Respir J 2002; 20: 813-818
Year: 2002



Evolution of serotype coverages of 23- and 7-valent pneumococcal vacciness for S. pneumonia isolates from Spanish middle age and older adults with pneumonia, 2002-2007
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008


Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes
Source: Eur Respir J 2014; 43: 545-553
Year: 2013




Impact of introducing the 10-valent pneumococcal conjugate vaccine on childhood hospitalizations for bacterial pneumonia in Brazil
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013

Impaired response to 13-valent pneumococcal conjugate vaccine (PCV13) in children with recurrent respiratory infections and chronic cough.
Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function
Year: 2021